Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-11

AUTHORS

N J Bahlis, A Corso, L-O Mugge, Z-X Shen, P Desjardins, A-M Stoppa, O Decaux, T de Revel, M Granell, G Marit, H Nahi, H Demuynck, S-Y Huang, S Basu, T H Guthrie, A Ervin-Haynes, J Marek, G Chen, T Facon

ABSTRACT

The phase 3, randomized Frontline Investigation of Revlimid and Dexamethasone Versus Standard Thalidomide (FIRST) trial investigating lenalidomide plus low-dose dexamethasone until disease progression (Rd continuous) vs melphalan, prednisone and thalidomide for 12 cycles (MPT) and Rd for 18 cycles (Rd18) in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM) showed that Rd continuous prolonged progression-free survival and overall survival compared with MPT. A subanalysis of the FIRST trial was conducted to determine the benefits of Rd continuous in patients with NDMM based on depth of response. Patients randomized 1:1:1 to Rd continuous, Rd18 or MPT were divided into subgroups based on best response: complete response (CR; n=290), ⩾very good partial response (VGPR; n=679), ⩾partial response (PR; n=1 225) or ⩽stable disease (n=299). Over 13% of patients receiving Rd continuous who achieved ⩾VGPR as best response did so beyond 18 months of treatment. Rd continuous reduced the risk of progression or death by 67%, 51% and 35% vs MPT in patients with CR, ⩾VGPR and ⩾PR, respectively. Similarly, Rd continuous reduced the risk of progression or death by 61%, 54% and 38% vs Rd18 in patients with CR, ⩾VGPR and ⩾PR, respectively. In patients with CR, ⩾VGPR or ⩾PR, 4-year survival rates in the Rd continuous arm (81.1%, 73.1% or 64.6%, respectively) were higher vs MPT (70.8%, 59.8% or 57.2%, respectively) and similar vs Rd18 (76.5%, 67.7% and 62.5%, respectively). Rd continuous improved efficacy outcomes in all responding patients, including those with CR, compared with fixed duration treatment. More... »

PAGES

2435

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/leu.2017.111

DOI

http://dx.doi.org/10.1038/leu.2017.111

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1084510691

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28373701


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dexamethasone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melphalan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Multiple Myeloma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prednisone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thalidomide", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Alberta Health Services", 
          "id": "https://www.grid.ac/institutes/grid.413574.0", 
          "name": [
            "Tom Baker Cancer Center-University of Calgary, Calgary, Alberta, Canada."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bahlis", 
        "givenName": "N J", 
        "id": "sg:person.01012164172.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012164172.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Pavia", 
          "id": "https://www.grid.ac/institutes/grid.8982.b", 
          "name": [
            "Policlinico San Matteo Universita Di Pavia, Pavia, Italy."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Corso", 
        "givenName": "A", 
        "id": "sg:person.0765250665.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765250665.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Jena University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.275559.9", 
          "name": [
            "Universit\u00e4tsklinikum Jena Klinik f\u00fcr Innere Medizin II, Jena, Germany."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mugge", 
        "givenName": "L-O", 
        "id": "sg:person.0771317052.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771317052.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shanghai Jiao Tong University", 
          "id": "https://www.grid.ac/institutes/grid.16821.3c", 
          "name": [
            "Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shen", 
        "givenName": "Z-X", 
        "id": "sg:person.0600616433.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600616433.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hopital Charles-LeMoyne", 
          "id": "https://www.grid.ac/institutes/grid.420748.d", 
          "name": [
            "H\u00f4pital Charles LeMoyne, Longueuil, Canada."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Desjardins", 
        "givenName": "P", 
        "id": "sg:person.01002216441.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002216441.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute Paoli-Calmettes", 
          "id": "https://www.grid.ac/institutes/grid.418443.e", 
          "name": [
            "Institut Paoli Calmettes, Marseille, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stoppa", 
        "givenName": "A-M", 
        "id": "sg:person.015101675464.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015101675464.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "CHRU H\u00f4pital Sud M\u00e9decine Interne, Rennes, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Decaux", 
        "givenName": "O", 
        "id": "sg:person.01276375576.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276375576.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital d'instruction des Arm\u00e9es Percy", 
          "id": "https://www.grid.ac/institutes/grid.414028.b", 
          "name": [
            "H\u00f4pital d'Instruction des Arm\u00e9es PERCY, Paris, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Revel", 
        "givenName": "T", 
        "id": "sg:person.01246300414.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246300414.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hospital de Sant Pau", 
          "id": "https://www.grid.ac/institutes/grid.413396.a", 
          "name": [
            "Hospital de la Santa Creu i Sant Pau, Barcelona, Spain."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Granell", 
        "givenName": "M", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier Universitaire de Bordeaux", 
          "id": "https://www.grid.ac/institutes/grid.42399.35", 
          "name": [
            "CHRU H\u00f4pital du Haut L\u00e9v\u00eaque, CHU de Bordeaux, Pessac, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marit", 
        "givenName": "G", 
        "id": "sg:person.0663277537.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663277537.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Karolinska University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.24381.3c", 
          "name": [
            "Karolinska University Hospital, Huddinge, Sweden."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nahi", 
        "givenName": "H", 
        "id": "sg:person.01346655130.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346655130.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "H. Hart Ziekenhuis Roeselare-Menen, Roeselare, Belgium."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Demuynck", 
        "givenName": "H", 
        "id": "sg:person.016613112373.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016613112373.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Taiwan University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.412094.a", 
          "name": [
            "National Taiwan University Hospital, Taipei City, Taiwan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "S-Y", 
        "id": "sg:person.016600345354.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016600345354.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "New Cross Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416051.7", 
          "name": [
            "New Cross Hospital, Wolverhampton, UK."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Basu", 
        "givenName": "S", 
        "id": "sg:person.01031540525.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031540525.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "21st Century Oncology (United States)", 
          "id": "https://www.grid.ac/institutes/grid.476819.5", 
          "name": [
            "21st Century Oncology, Jacksonville, FL, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guthrie", 
        "givenName": "T H", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Celgene (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418722.a", 
          "name": [
            "Celgene Corporation, Summit, NJ, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ervin-Haynes", 
        "givenName": "A", 
        "id": "sg:person.0611013300.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611013300.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Celgene (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418722.a", 
          "name": [
            "Celgene Corporation, Summit, NJ, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marek", 
        "givenName": "J", 
        "id": "sg:person.0742510353.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742510353.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Celgene (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418722.a", 
          "name": [
            "Celgene Corporation, Summit, NJ, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "G", 
        "id": "sg:person.0760250477.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760250477.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "H\u00f4pital Claude Huriez", 
          "id": "https://www.grid.ac/institutes/grid.413875.c", 
          "name": [
            "Service des Maladies du Sang, H\u00f4pital Claude Huriez, CHRU Lille, Lille, France."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Facon", 
        "givenName": "T", 
        "id": "sg:person.01125032152.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125032152.62"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3816/clml.2010.n.120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013210054"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2013.220", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017507834", 
          "https://doi.org/10.1038/leu.2013.220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2009-03-211953", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019111246"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2010-09-307645", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019656561"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leusup.2013.5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025142681", 
          "https://doi.org/10.1038/leusup.2013.5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.49.0086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026808845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23546", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031068927"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2009.015917", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031130867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404284", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033553106", 
          "https://doi.org/10.1038/sj.leu.2404284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2404284", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033553106", 
          "https://doi.org/10.1038/sj.leu.2404284"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/leu.2010.313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034730993", 
          "https://doi.org/10.1038/leu.2010.313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(07)61537-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037699397"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.0948", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040245441"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1155/2014/456037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041179576"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2014-01-550020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041943451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-02-338665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042868402"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0801479", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043382081"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1402551", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048449895"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.41.6180", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048463328"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2013.0007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078673181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6004/jnccn.2013.0007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078673181"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-11", 
    "datePublishedReg": "2017-11-01", 
    "description": "The phase 3, randomized Frontline Investigation of Revlimid and Dexamethasone Versus Standard Thalidomide (FIRST) trial investigating lenalidomide plus low-dose dexamethasone until disease progression (Rd continuous) vs melphalan, prednisone and thalidomide for 12 cycles (MPT) and Rd for 18 cycles (Rd18) in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM) showed that Rd continuous prolonged progression-free survival and overall survival compared with MPT. A subanalysis of the FIRST trial was conducted to determine the benefits of Rd continuous in patients with NDMM based on depth of response. Patients randomized 1:1:1 to Rd continuous, Rd18 or MPT were divided into subgroups based on best response: complete response (CR; n=290), \u2a7every good partial response (VGPR; n=679), \u2a7epartial response (PR; n=1 225) or \u2a7dstable disease (n=299). Over 13% of patients receiving Rd continuous who achieved \u2a7eVGPR as best response did so beyond 18 months of treatment. Rd continuous reduced the risk of progression or death by 67%, 51% and 35% vs MPT in patients with CR, \u2a7eVGPR and \u2a7ePR, respectively. Similarly, Rd continuous reduced the risk of progression or death by 61%, 54% and 38% vs Rd18 in patients with CR, \u2a7eVGPR and \u2a7ePR, respectively. In patients with CR, \u2a7eVGPR or \u2a7ePR, 4-year survival rates in the Rd continuous arm (81.1%, 73.1% or 64.6%, respectively) were higher vs MPT (70.8%, 59.8% or 57.2%, respectively) and similar vs Rd18 (76.5%, 67.7% and 62.5%, respectively). Rd continuous improved efficacy outcomes in all responding patients, including those with CR, compared with fixed duration treatment.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/leu.2017.111", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1097065", 
        "issn": [
          "0887-6924", 
          "1476-5551"
        ], 
        "name": "Leukemia", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "31"
      }
    ], 
    "name": "Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial", 
    "pagination": "2435", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "4089e22ad7cc52bd30cd0a1a07b12bd9a145a3a59ad5fca73610cf93390e5a60"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28373701"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8704895"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/leu.2017.111"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1084510691"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/leu.2017.111", 
      "https://app.dimensions.ai/details/publication/pub.1084510691"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000422.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/leu2017111"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.111'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.111'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.111'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/leu.2017.111'


 

This table displays all metadata directly associated to this object as RDF triples.

352 TRIPLES      21 PREDICATES      61 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/leu.2017.111 schema:about N0276b5f7fac44b96bd8832016d545657
2 N0b511f5641124d43902593dc04721190
3 N2b8e2e5d8e544a32a6c49adfb757f728
4 N43d439a3629a46fc86066241720cca1e
5 N5bf67a975451416981e88d2510e559ca
6 N5dc8df04ed384573b1911a6b7bd81817
7 N6e9b1692d6e8403c80c2cd66aeb82cc4
8 N92d1a591603e473aadc222d1ed667da4
9 N9b0071648d3e4013af09159a5293c947
10 Nbf1252135ff54cc39ad57c85b685df03
11 Nf08e1809f89c446cb36466040235868e
12 Nf570bc537d2d40e2b585cd1f9194a62a
13 Nf6b302320406481fa84a911baf7f4f3a
14 anzsrc-for:11
15 anzsrc-for:1103
16 schema:author N7ff0e3bb6be546f29680f6fccce33d38
17 schema:citation sg:pub.10.1038/leu.2010.313
18 sg:pub.10.1038/leu.2013.220
19 sg:pub.10.1038/leusup.2013.5
20 sg:pub.10.1038/sj.leu.2404284
21 https://doi.org/10.1002/cncr.23546
22 https://doi.org/10.1016/s0140-6736(07)61537-2
23 https://doi.org/10.1056/nejmoa0801479
24 https://doi.org/10.1056/nejmoa1402551
25 https://doi.org/10.1155/2014/456037
26 https://doi.org/10.1182/blood-2009-03-211953
27 https://doi.org/10.1182/blood-2010-09-307645
28 https://doi.org/10.1182/blood-2011-02-338665
29 https://doi.org/10.1182/blood-2014-01-550020
30 https://doi.org/10.1200/jco.2008.21.0948
31 https://doi.org/10.1200/jco.2012.41.6180
32 https://doi.org/10.1200/jco.2013.49.0086
33 https://doi.org/10.3324/haematol.2009.015917
34 https://doi.org/10.3816/clml.2010.n.120
35 https://doi.org/10.6004/jnccn.2013.0007
36 schema:datePublished 2017-11
37 schema:datePublishedReg 2017-11-01
38 schema:description The phase 3, randomized Frontline Investigation of Revlimid and Dexamethasone Versus Standard Thalidomide (FIRST) trial investigating lenalidomide plus low-dose dexamethasone until disease progression (Rd continuous) vs melphalan, prednisone and thalidomide for 12 cycles (MPT) and Rd for 18 cycles (Rd18) in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM) showed that Rd continuous prolonged progression-free survival and overall survival compared with MPT. A subanalysis of the FIRST trial was conducted to determine the benefits of Rd continuous in patients with NDMM based on depth of response. Patients randomized 1:1:1 to Rd continuous, Rd18 or MPT were divided into subgroups based on best response: complete response (CR; n=290), ⩾very good partial response (VGPR; n=679), ⩾partial response (PR; n=1 225) or ⩽stable disease (n=299). Over 13% of patients receiving Rd continuous who achieved ⩾VGPR as best response did so beyond 18 months of treatment. Rd continuous reduced the risk of progression or death by 67%, 51% and 35% vs MPT in patients with CR, ⩾VGPR and ⩾PR, respectively. Similarly, Rd continuous reduced the risk of progression or death by 61%, 54% and 38% vs Rd18 in patients with CR, ⩾VGPR and ⩾PR, respectively. In patients with CR, ⩾VGPR or ⩾PR, 4-year survival rates in the Rd continuous arm (81.1%, 73.1% or 64.6%, respectively) were higher vs MPT (70.8%, 59.8% or 57.2%, respectively) and similar vs Rd18 (76.5%, 67.7% and 62.5%, respectively). Rd continuous improved efficacy outcomes in all responding patients, including those with CR, compared with fixed duration treatment.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree true
42 schema:isPartOf N2721f35e869840d1943dfce2896fb125
43 N7ada9c8a6e1b4da8b88683c0efd84ca1
44 sg:journal.1097065
45 schema:name Benefit of continuous treatment for responders with newly diagnosed multiple myeloma in the randomized FIRST trial
46 schema:pagination 2435
47 schema:productId N1ae5866298f54d84899d4bb8e94a405d
48 N445b09918125481497a19f7eb687f1ea
49 N538750f8e9b44a8b986bb9fac6db08e0
50 N641847e3f48145bfb6e6daa61ffd5fc6
51 Nde95d2559a0d4f6d9febdf8204f26302
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084510691
53 https://doi.org/10.1038/leu.2017.111
54 schema:sdDatePublished 2019-04-10T17:19
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher N7b570068a6554cc2852e3d74641b67ec
57 schema:url https://www.nature.com/articles/leu2017111
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N000a21bfaca5430b99ccf44f23d086fb rdf:first sg:person.01246300414.38
62 rdf:rest N14947c26fd4c495d99625b4b02222475
63 N0276b5f7fac44b96bd8832016d545657 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Antineoplastic Combined Chemotherapy Protocols
65 rdf:type schema:DefinedTerm
66 N090a168202ae4b4e8cb251e219c428f0 rdf:first sg:person.015101675464.51
67 rdf:rest N6eb46e79a5e645058712c49123d96f17
68 N0b511f5641124d43902593dc04721190 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Aged
70 rdf:type schema:DefinedTerm
71 N0f8b8925304a4f8681f1cb7da88f5c4e rdf:first sg:person.01346655130.17
72 rdf:rest N4bc50e562d2e4b87a804f6dd0cf47e92
73 N123408aa22ed4df4b22f0936d267e460 rdf:first sg:person.016600345354.31
74 rdf:rest N494ae5a91a8e465eb6f94fdab7cb0c85
75 N14947c26fd4c495d99625b4b02222475 rdf:first N1674ec6e96344e988e79583da091caa4
76 rdf:rest Nb2a37b1621b94750b66446d80aa00558
77 N1674ec6e96344e988e79583da091caa4 schema:affiliation https://www.grid.ac/institutes/grid.413396.a
78 schema:familyName Granell
79 schema:givenName M
80 rdf:type schema:Person
81 N17113022404e41d9bb25c2dfb1a973fe rdf:first sg:person.0771317052.95
82 rdf:rest N2326f7433a4b43d6af14de05206ba120
83 N1ae5866298f54d84899d4bb8e94a405d schema:name doi
84 schema:value 10.1038/leu.2017.111
85 rdf:type schema:PropertyValue
86 N2326f7433a4b43d6af14de05206ba120 rdf:first sg:person.0600616433.10
87 rdf:rest Naef65b9c56054172912f568063d16c63
88 N2721f35e869840d1943dfce2896fb125 schema:issueNumber 11
89 rdf:type schema:PublicationIssue
90 N2b8e2e5d8e544a32a6c49adfb757f728 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Adult
92 rdf:type schema:DefinedTerm
93 N43d439a3629a46fc86066241720cca1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Multiple Myeloma
95 rdf:type schema:DefinedTerm
96 N445b09918125481497a19f7eb687f1ea schema:name dimensions_id
97 schema:value pub.1084510691
98 rdf:type schema:PropertyValue
99 N494ae5a91a8e465eb6f94fdab7cb0c85 rdf:first sg:person.01031540525.68
100 rdf:rest N8ebe67b5ef1f43db91d8a02ffd8d303f
101 N4bc50e562d2e4b87a804f6dd0cf47e92 rdf:first sg:person.016613112373.61
102 rdf:rest N123408aa22ed4df4b22f0936d267e460
103 N538750f8e9b44a8b986bb9fac6db08e0 schema:name pubmed_id
104 schema:value 28373701
105 rdf:type schema:PropertyValue
106 N5bf67a975451416981e88d2510e559ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Melphalan
108 rdf:type schema:DefinedTerm
109 N5dc8df04ed384573b1911a6b7bd81817 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Aged, 80 and over
111 rdf:type schema:DefinedTerm
112 N6188630ff507426480a2ccb78123fcb2 rdf:first sg:person.0760250477.44
113 rdf:rest N818e4423fba04af9b40d3cbbbcf473c9
114 N641847e3f48145bfb6e6daa61ffd5fc6 schema:name readcube_id
115 schema:value 4089e22ad7cc52bd30cd0a1a07b12bd9a145a3a59ad5fca73610cf93390e5a60
116 rdf:type schema:PropertyValue
117 N6e9b1692d6e8403c80c2cd66aeb82cc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N6eb46e79a5e645058712c49123d96f17 rdf:first sg:person.01276375576.23
121 rdf:rest N000a21bfaca5430b99ccf44f23d086fb
122 N7ada9c8a6e1b4da8b88683c0efd84ca1 schema:volumeNumber 31
123 rdf:type schema:PublicationVolume
124 N7b570068a6554cc2852e3d74641b67ec schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N7ff0e3bb6be546f29680f6fccce33d38 rdf:first sg:person.01012164172.15
127 rdf:rest Nd4deadf04edf4e158f418b82d85fb4ea
128 N818e4423fba04af9b40d3cbbbcf473c9 rdf:first sg:person.01125032152.62
129 rdf:rest rdf:nil
130 N8ebe67b5ef1f43db91d8a02ffd8d303f rdf:first Nf1462c0fba334acb823a54df64302641
131 rdf:rest Nf265b954c3a74737a892d4ac93a242f4
132 N92d1a591603e473aadc222d1ed667da4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Prednisone
134 rdf:type schema:DefinedTerm
135 N9b0071648d3e4013af09159a5293c947 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Thalidomide
137 rdf:type schema:DefinedTerm
138 Naef65b9c56054172912f568063d16c63 rdf:first sg:person.01002216441.96
139 rdf:rest N090a168202ae4b4e8cb251e219c428f0
140 Nb2a37b1621b94750b66446d80aa00558 rdf:first sg:person.0663277537.07
141 rdf:rest N0f8b8925304a4f8681f1cb7da88f5c4e
142 Nbf1252135ff54cc39ad57c85b685df03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Female
144 rdf:type schema:DefinedTerm
145 Nc39004faf1a746e480df475577f7305a rdf:first sg:person.0742510353.17
146 rdf:rest N6188630ff507426480a2ccb78123fcb2
147 Nd1687b9d09e54ea6a86bcd53373a2a5b schema:name CHRU Hôpital Sud Médecine Interne, Rennes, France.
148 rdf:type schema:Organization
149 Nd4deadf04edf4e158f418b82d85fb4ea rdf:first sg:person.0765250665.41
150 rdf:rest N17113022404e41d9bb25c2dfb1a973fe
151 Nde95d2559a0d4f6d9febdf8204f26302 schema:name nlm_unique_id
152 schema:value 8704895
153 rdf:type schema:PropertyValue
154 Ne947c3ebf7be4ed08a92bcd1b1416ddb schema:name H. Hart Ziekenhuis Roeselare-Menen, Roeselare, Belgium.
155 rdf:type schema:Organization
156 Nf08e1809f89c446cb36466040235868e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Middle Aged
158 rdf:type schema:DefinedTerm
159 Nf1462c0fba334acb823a54df64302641 schema:affiliation https://www.grid.ac/institutes/grid.476819.5
160 schema:familyName Guthrie
161 schema:givenName T H
162 rdf:type schema:Person
163 Nf265b954c3a74737a892d4ac93a242f4 rdf:first sg:person.0611013300.29
164 rdf:rest Nc39004faf1a746e480df475577f7305a
165 Nf570bc537d2d40e2b585cd1f9194a62a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Dexamethasone
167 rdf:type schema:DefinedTerm
168 Nf6b302320406481fa84a911baf7f4f3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
169 schema:name Male
170 rdf:type schema:DefinedTerm
171 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
172 schema:name Medical and Health Sciences
173 rdf:type schema:DefinedTerm
174 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
175 schema:name Clinical Sciences
176 rdf:type schema:DefinedTerm
177 sg:journal.1097065 schema:issn 0887-6924
178 1476-5551
179 schema:name Leukemia
180 rdf:type schema:Periodical
181 sg:person.01002216441.96 schema:affiliation https://www.grid.ac/institutes/grid.420748.d
182 schema:familyName Desjardins
183 schema:givenName P
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01002216441.96
185 rdf:type schema:Person
186 sg:person.01012164172.15 schema:affiliation https://www.grid.ac/institutes/grid.413574.0
187 schema:familyName Bahlis
188 schema:givenName N J
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01012164172.15
190 rdf:type schema:Person
191 sg:person.01031540525.68 schema:affiliation https://www.grid.ac/institutes/grid.416051.7
192 schema:familyName Basu
193 schema:givenName S
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031540525.68
195 rdf:type schema:Person
196 sg:person.01125032152.62 schema:affiliation https://www.grid.ac/institutes/grid.413875.c
197 schema:familyName Facon
198 schema:givenName T
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125032152.62
200 rdf:type schema:Person
201 sg:person.01246300414.38 schema:affiliation https://www.grid.ac/institutes/grid.414028.b
202 schema:familyName de Revel
203 schema:givenName T
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246300414.38
205 rdf:type schema:Person
206 sg:person.01276375576.23 schema:affiliation Nd1687b9d09e54ea6a86bcd53373a2a5b
207 schema:familyName Decaux
208 schema:givenName O
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276375576.23
210 rdf:type schema:Person
211 sg:person.01346655130.17 schema:affiliation https://www.grid.ac/institutes/grid.24381.3c
212 schema:familyName Nahi
213 schema:givenName H
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346655130.17
215 rdf:type schema:Person
216 sg:person.015101675464.51 schema:affiliation https://www.grid.ac/institutes/grid.418443.e
217 schema:familyName Stoppa
218 schema:givenName A-M
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015101675464.51
220 rdf:type schema:Person
221 sg:person.016600345354.31 schema:affiliation https://www.grid.ac/institutes/grid.412094.a
222 schema:familyName Huang
223 schema:givenName S-Y
224 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016600345354.31
225 rdf:type schema:Person
226 sg:person.016613112373.61 schema:affiliation Ne947c3ebf7be4ed08a92bcd1b1416ddb
227 schema:familyName Demuynck
228 schema:givenName H
229 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016613112373.61
230 rdf:type schema:Person
231 sg:person.0600616433.10 schema:affiliation https://www.grid.ac/institutes/grid.16821.3c
232 schema:familyName Shen
233 schema:givenName Z-X
234 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600616433.10
235 rdf:type schema:Person
236 sg:person.0611013300.29 schema:affiliation https://www.grid.ac/institutes/grid.418722.a
237 schema:familyName Ervin-Haynes
238 schema:givenName A
239 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0611013300.29
240 rdf:type schema:Person
241 sg:person.0663277537.07 schema:affiliation https://www.grid.ac/institutes/grid.42399.35
242 schema:familyName Marit
243 schema:givenName G
244 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663277537.07
245 rdf:type schema:Person
246 sg:person.0742510353.17 schema:affiliation https://www.grid.ac/institutes/grid.418722.a
247 schema:familyName Marek
248 schema:givenName J
249 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742510353.17
250 rdf:type schema:Person
251 sg:person.0760250477.44 schema:affiliation https://www.grid.ac/institutes/grid.418722.a
252 schema:familyName Chen
253 schema:givenName G
254 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760250477.44
255 rdf:type schema:Person
256 sg:person.0765250665.41 schema:affiliation https://www.grid.ac/institutes/grid.8982.b
257 schema:familyName Corso
258 schema:givenName A
259 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0765250665.41
260 rdf:type schema:Person
261 sg:person.0771317052.95 schema:affiliation https://www.grid.ac/institutes/grid.275559.9
262 schema:familyName Mugge
263 schema:givenName L-O
264 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0771317052.95
265 rdf:type schema:Person
266 sg:pub.10.1038/leu.2010.313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034730993
267 https://doi.org/10.1038/leu.2010.313
268 rdf:type schema:CreativeWork
269 sg:pub.10.1038/leu.2013.220 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017507834
270 https://doi.org/10.1038/leu.2013.220
271 rdf:type schema:CreativeWork
272 sg:pub.10.1038/leusup.2013.5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025142681
273 https://doi.org/10.1038/leusup.2013.5
274 rdf:type schema:CreativeWork
275 sg:pub.10.1038/sj.leu.2404284 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033553106
276 https://doi.org/10.1038/sj.leu.2404284
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1002/cncr.23546 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031068927
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1016/s0140-6736(07)61537-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037699397
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1056/nejmoa0801479 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043382081
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1056/nejmoa1402551 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048449895
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1155/2014/456037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041179576
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1182/blood-2009-03-211953 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019111246
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1182/blood-2010-09-307645 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019656561
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1182/blood-2011-02-338665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042868402
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1182/blood-2014-01-550020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041943451
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1200/jco.2008.21.0948 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040245441
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1200/jco.2012.41.6180 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048463328
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1200/jco.2013.49.0086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026808845
301 rdf:type schema:CreativeWork
302 https://doi.org/10.3324/haematol.2009.015917 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031130867
303 rdf:type schema:CreativeWork
304 https://doi.org/10.3816/clml.2010.n.120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013210054
305 rdf:type schema:CreativeWork
306 https://doi.org/10.6004/jnccn.2013.0007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078673181
307 rdf:type schema:CreativeWork
308 https://www.grid.ac/institutes/grid.16821.3c schema:alternateName Shanghai Jiao Tong University
309 schema:name Ruijin Hospital, Shanghai Jiao Tong University, Shanghai, China.
310 rdf:type schema:Organization
311 https://www.grid.ac/institutes/grid.24381.3c schema:alternateName Karolinska University Hospital
312 schema:name Karolinska University Hospital, Huddinge, Sweden.
313 rdf:type schema:Organization
314 https://www.grid.ac/institutes/grid.275559.9 schema:alternateName Jena University Hospital
315 schema:name Universitätsklinikum Jena Klinik für Innere Medizin II, Jena, Germany.
316 rdf:type schema:Organization
317 https://www.grid.ac/institutes/grid.412094.a schema:alternateName National Taiwan University Hospital
318 schema:name National Taiwan University Hospital, Taipei City, Taiwan.
319 rdf:type schema:Organization
320 https://www.grid.ac/institutes/grid.413396.a schema:alternateName Hospital de Sant Pau
321 schema:name Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
322 rdf:type schema:Organization
323 https://www.grid.ac/institutes/grid.413574.0 schema:alternateName Alberta Health Services
324 schema:name Tom Baker Cancer Center-University of Calgary, Calgary, Alberta, Canada.
325 rdf:type schema:Organization
326 https://www.grid.ac/institutes/grid.413875.c schema:alternateName Hôpital Claude Huriez
327 schema:name Service des Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France.
328 rdf:type schema:Organization
329 https://www.grid.ac/institutes/grid.414028.b schema:alternateName Hôpital d'instruction des Armées Percy
330 schema:name Hôpital d'Instruction des Armées PERCY, Paris, France.
331 rdf:type schema:Organization
332 https://www.grid.ac/institutes/grid.416051.7 schema:alternateName New Cross Hospital
333 schema:name New Cross Hospital, Wolverhampton, UK.
334 rdf:type schema:Organization
335 https://www.grid.ac/institutes/grid.418443.e schema:alternateName Institute Paoli-Calmettes
336 schema:name Institut Paoli Calmettes, Marseille, France.
337 rdf:type schema:Organization
338 https://www.grid.ac/institutes/grid.418722.a schema:alternateName Celgene (United States)
339 schema:name Celgene Corporation, Summit, NJ, USA.
340 rdf:type schema:Organization
341 https://www.grid.ac/institutes/grid.420748.d schema:alternateName Hopital Charles-LeMoyne
342 schema:name Hôpital Charles LeMoyne, Longueuil, Canada.
343 rdf:type schema:Organization
344 https://www.grid.ac/institutes/grid.42399.35 schema:alternateName Centre Hospitalier Universitaire de Bordeaux
345 schema:name CHRU Hôpital du Haut Lévêque, CHU de Bordeaux, Pessac, France.
346 rdf:type schema:Organization
347 https://www.grid.ac/institutes/grid.476819.5 schema:alternateName 21st Century Oncology (United States)
348 schema:name 21st Century Oncology, Jacksonville, FL, USA.
349 rdf:type schema:Organization
350 https://www.grid.ac/institutes/grid.8982.b schema:alternateName University of Pavia
351 schema:name Policlinico San Matteo Universita Di Pavia, Pavia, Italy.
352 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...